Gold tier: mechanically validated evidence, with its primary source.
148 evidence items · page 2 / 6
23.4 %In the study, 23.4% of the 801 students in four secondary schools in Benin City, Nigeria, received the HPV vaccine.
Nigeriainfection à HPVpublished 2026International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument of 10 observations
7,700,000 girlsIn October 2023, Nigeria integrated the single-dose human papillomavirus (HPV) vaccine into its routine immunization program, aiming to protect 7.7 million girls aged 9 to 14 years.
Nigeriainfection à HPVobserved October 2023published 2024Cancer prevention research (Philadelphia, Pa.)PubMed
40.1 %Concern about the safety of the HPV vaccine was reported as a barrier by 40.1% of female undergraduates in a university in Ekiti State, southwest Nigeria.
Nigeriainfection à HPVpublished 2023African journal of reproductive healthPubMeddocument of 5 observations
36.2 %36.2% of the participants recognized that HPV can be transmitted via skin-to-skin contact.
Nigeriainfection à HPVpublished 2024BMC public healthPubMeddocument of 12 observations
hrHPV infection was defined as detection of at least one carcinogenic HPV genotype in a sample provided at the baseline visit.
NigeriahrHPV · infection à HPVpublished 2020BMC medical geneticsPubMeddocument of 6 observations
6 HPV_typesAmong these 25 HPV types in Nigeria, only six were included in the current nine-valent HPV vaccine.
Nigeriainfection à HPVpublished 2023Virology journalPubMeddocument of 8 observations
31.15 %Among the PCR-confirmed HPV types, 31.15% were undetermined HPV types.
Nigeriainfection à HPVpublished 2023Virology journalPubMeddocument of 8 observations
82.1 %Awareness of HPV-associated anal cancer was 82.1% among the participants.
Nigeriaanal cancer · infection à HPVpublished 2025Sexual healthPubMeddocument of 9 observations
53 %Inadequate awareness about the HPV vaccine was reported as a barrier by 53.0% of female undergraduates in a university in Ekiti State, southwest Nigeria.
Nigeriainfection à HPVpublished 2023African journal of reproductive healthPubMeddocument of 5 observations
24 %The prevalence of any HPV infection was 24% in the oral cavity among female sex workers in Ibadan, Nigeria.
Nigeriainfection à HPVpublished 2022PloS oneeurope_pmcdocument of 4 observations
3 casesThree mothers living with HIV had received HPV vaccination.
Nigeriainfection à HPVpublished 2026BMC public healthPubMeddocument of 8 observations
15.8 %Awareness of HPV-associated penile cancer was 15.8% among the participants.
Nigeriainfection à HPV · penile cancerpublished 2025Sexual healthPubMeddocument of 9 observations
100 %All the respondents had heard of HPV vaccine.
Nigeriainfection à HPVpublished 2024Reproductive healthPubMeddocument of 16 observations
12 %Among 213 women aged 16 to 63 years recruited in Lagos, Nigeria, 26 out of 213 participants had discordant HPV test results, representing 12% of total participants.
Nigeriainfection à HPVobserved 2020published 2022BMC public healthPubMeddocument of 5 observations
20.8 %Among HPV-positive individuals, 20.8% had dual infections.
Nigeriainfection à HPVpublished 2019PloS onePubMeddocument of 7 observations
0 %Vaccination uptake among adolescents aged 9–14 years increased from 0% to 5.4%, with statistical significance (p < 0.0001).
Nigeriainfection à HPVpublished 2026Journal of the International AIDS SocietyPubMeddocument of 5 observations
37 %The pooled prevalence of cervical papillomavirus infection was 37% among women living with HIV/AIDS in Nigeria.
Nigeriainfection à HPVpublished 2020Asian Pacific journal of cancer prevention : APJCPPubMeddocument of 2 observations
21 %Following a positive HPV result, 21% of women referred completed triage examination.
Nigeriainfection à HPVobserved 2021published 2023BMC public healthPubMeddocument of 12 observations
29 cases29 out of 507 mothers living with HIV were informed about the HPV vaccine.
Nigeriainfection à HPVpublished 2026BMC public healthPubMeddocument of 8 observations
56.3 %In the study, 56.3% of refusals for the HPV vaccine were due to fear of side effects among students in four secondary schools in Benin City, Nigeria.
Nigeriainfection à HPVpublished 2026International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument of 10 observations
54.1 %Overall HPV prevalence was 54.1% among a cohort of 220 HIV-infected women attending the antiretroviral clinic of the Federal Medical Centre, Keffi, Nigeria.
Nigeriainfection à HPVpublished 2019The Pan African medical journalPubMeddocument of 5 observations
50.9 %50.9% of the participants acknowledged that early sexual debut increases the risk of acquiring HPV.
Nigeriainfection à HPVpublished 2024BMC public healthPubMeddocument of 12 observations
97.6 %Most entries (42/43, 97.6%) focused on cervical cancer and human papillomavirus.
Nigeriacancer du col de l'utérus · infection à HPVpublished 2026JMIR formative researchPubMeddocument of 7 observations
93.6 %Among 249 sexual minority men living with HIV in Abuja, Nigeria, 93.6% reported willingness to receive HPV vaccine.
Nigeriainfection à HPVpublished 2026Sexual healthPubMeddocument of 6 observations
32.7 %HPV vaccine acceptance ranged from 32.7% to 97.3% in studies conducted in Nigeria.
Nigeriainfection à HPVpublished 2026BMC public healthPubMeddocument of 3 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.